Showing 1 - 1 of 1 results
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Conditions:
Rofecoxib is a nonsteroidal anti-inflammatory drug which selectively inhibits COX-2 and subsequent prostaglandin synthesis. The drug was developed by Merk and approved by FDA in 1999 for relief of signs and symptoms of arthritis, acute pain in adults...